Stockscreener 앱 받기
19.44
1.62%
-0.32
전일 마감가:
$19.76
열려 있는:
$19.69
하루 거래량:
549.61K
Relative Volume:
0.64
시가총액:
$1.45B
수익:
$384.03M
순이익/손실:
$38.65M
주가수익비율:
62.71
EPS:
0.31
순현금흐름:
$196.35M
1주 성능:
-0.72%
1개월 성능:
-2.41%
6개월 성능:
-4.00%
1년 성능:
+5.37%
1일 변동 폭
$19.36
$19.80
1주일 범위
$19.00
$19.90
52주 변동 폭
$16.52
$22.76
Innoviva Inc Stock (INVA) Company Profile
명칭
Innoviva Inc
전화
(650) 238-9600
주소
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
INVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
19.44 | 1.48B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 개시 | Goldman | Sell |
| 2025-08-11 | 개시 | Oppenheimer | Outperform |
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-20 | 개시 | Goldman | Neutral |
| 2017-11-20 | 개시 | Deutsche Bank | Hold |
모두보기
Innoviva Inc 주식(INVA)의 최신 뉴스
Cantor Fitzgerald Maintains and Raises Price Target for INVA | I - GuruFocus
Innoviva (NASDAQ:INVA) Shares Cross Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Innoviva, Inc. (INVA) Stock Analysis: Exploring a 67% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Understanding Momentum Shifts in (INVA) - Stock Traders Daily
Innoviva (INVA) price target decreased by 12.36% to 32.90 - MSN
Can Innoviva Inc. stock beat market expectations this quarterStability vs Neutral Overview & support options for steady strides - Улправда
Innoviva, Inc.Common Stock (NQ: INVA - FinancialContent
Volume Recap: Can Innoviva Inc. stock beat market expectations this quarterJuly 2025 Review & Safe Capital Growth Tips - Улправда
Is Innoviva Inc. stock positioned for digital transformationOil Prices & High Return Trade Guides - Улправда
Is Innoviva Inc. stock in correction or buying zoneJuly 2025 Macro Moves & Weekly Setup with ROI Potential - ulpravda.ru
Los Angeles Daily NewsInnoviva, Inc.Common Stock (Nasdaq:INVA) Detailed Stock Data - FinancialContent
Is Innoviva Inc. (HVE) stock good for wealth creationJuly 2025 Big Picture & Real-Time Buy Zone Alerts - ulpravda.ru
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out - Investing.com
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Innoviva, Inc. (INVA) Stock Report: Exploring A 62% Upside Potential - DirectorsTalk Interviews
Will Innoviva Inc. (HVE) stock recover faster than industry2026 world cup usa national team quarterfinals defensive leaders low block defense knockout prediction preview - ulpravda.ru
Synergy Asset Management LLC Invests $1.85 Million in Innoviva, Inc. $INVA - MarketBeat
INVA Stock Price, Forecast & Analysis | INNOVIVA INC (NASDAQ:INVA) - Chartmill
Avoiding Lag: Real-Time Signals in (INVA) Movement - Stock Traders Daily
Innoviva’s Stock Under the Microscope: Is INVA Quietly Setting Up Its Next Move? - AD HOC NEWS
Innoviva joins elite list of stocks with 95-plus composite rating - MSN
Pacer Advisors Inc. Sells 48,889 Shares of Innoviva, Inc. $INVA - Defense World
Scotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform Recommendation - MSN
Is Innoviva Inc stock in correction or buying zoneJuly 2025 Reactions & Community Trade Idea Sharing Platform - Bộ Nội Vụ
Despite Lower Earnings Than Five Years Ago, Innoviva (NASDAQ:INVA) Investors Are up 65% Since Then - 富途牛牛
Innoviva (INVA): Valuation Check After FDA Approval of First-in-Class NUZOLVENCE Antibiotic - Sahm
Innoviva (NASDAQ:INVA) Share Price Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Innoviva Inc (NASDAQ:INVA) Nasdaq Composite ETF Therapy Royalties - Kalkine Media
Is Innoviva Inc a good long term investmentMarket Sentiment Report & Small Investment Portfolio - earlytimes.in
December 2026 Options Now Available For Innoviva (INVA) - Nasdaq
How Investors May Respond To Innoviva (INVA) Winning FDA Approval For First-In-Class Gonorrhea Drug - Sahm
H.C. Wainwright Lifts PT on Innoviva (INVA) to $46 From $45, Keeps a Buy Rating - Finviz
Technical Reactions to INVA Trends in Macro Strategies - Stock Traders Daily
Will Innoviva Inc. stock attract ESG investorsTrade Exit Report & Daily Profit Maximizing Trade Tips - Улправда
Will Innoviva Inc. (HVE) stock justify high valuation2025 Volatility Report & Weekly Watchlist for Consistent Profits - Улправда
12 Small Cap Stocks to Buy with Huge Upside Potential - Insider Monkey
Can Innoviva Inc. stock deliver surprise earnings beatMarket Growth Summary & Low Drawdown Momentum Ideas - Улправда
Aug Fed Impact: How Innoviva Inc. (HVE) stock compares with tech leadersInsider Selling & Short-Term High Return Ideas - Улправда
Can Innoviva Inc. (HVE) stock deliver double digit returnsJuly 2025 Weekly Recap & Daily Stock Trend Reports - Улправда
Is Innoviva Still Attractive Around $20 After Strong Multi Year Share Price Gains? - Yahoo Finance
How Innoviva Inc. stock responds to policy changesQuarterly Portfolio Review & Free Safe Entry Trade Signal Reports - DonanımHaber
Why Innoviva Inc. stock is in analyst buy zoneWeekly Risk Summary & Stock Portfolio Risk Control - DonanımHaber
Can Innoviva Inc. stock deliver sustainable ROENew Guidance & Low Risk Entry Point Guides - DonanımHaber
Profit Recap: Can Innoviva Inc. (HVE) stock deliver double digit returnsJuly 2025 Catalysts & Weekly Stock Performance Updates - Улправда
Will Innoviva Inc. stock see PE expansion2025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
Innoviva, Inc. (NASDAQ:INVA) Receives $38.60 Average Target Price from Analysts - Defense World
HC Wainwright & Co. Maintains Innoviva (INVA) Buy Recommendation - Nasdaq
Innoviva Inc (INVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Innoviva Inc 주식 (INVA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
4.73%
0.92%
자본화:
|
볼륨(24시간):